These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4287511)

  • 41. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Contribution to the study of the interference of the renin-angiotensin-aldosterone system during the development of chronic alcoholic hepatopathy].
    Bourel M; Pirot D; Lenoir P; Chauvel A; Pawlotsky Y; Simon M
    Rev Int Hepatol; 1968; 18(7):871-94. PubMed ID: 4307168
    [No Abstract]   [Full Text] [Related]  

  • 43. [Inhibition of natriuretic effect of angiotensin by spirolactones and salidiuretics in cirrhosis and arterial hypertension].
    Kuntzmann F; Reville P; Kurtz T; Jahn H; Stahl J
    Pathol Biol (Paris); 1969 May; 17(9):447-58. PubMed ID: 4308377
    [No Abstract]   [Full Text] [Related]  

  • 44. The physiology of renin.
    Stein JH; Ferris TF
    Arch Intern Med; 1973 Jun; 131(6):860-72. PubMed ID: 4350440
    [No Abstract]   [Full Text] [Related]  

  • 45. [Renal insufficiency in decompensated liver cirrhosis. Report of 5 cases and a review of the pathophysiology].
    Thomsen AC
    Ugeskr Laeger; 1968 Apr; 130(14):585-91. PubMed ID: 4303382
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
    Clària J; Kent JD; López-Parra M; Escolar G; Ruiz-Del-Arbol L; Ginès P; Jiménez W; Vucelic B; Arroyo V
    Hepatology; 2005 Mar; 41(3):579-87. PubMed ID: 15723448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
    Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
    Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dynamic functions of angiotensin in hypertension: renal effects as the basic cause of chronic hypertension.
    Guyton AC; Cowley AW; Fagard R; Langford HG; McCaa RE; DeClue JW; Coleman TG; Barnes GE
    Acta Physiol Lat Am; 1974; 24(5):592-5. PubMed ID: 4377512
    [No Abstract]   [Full Text] [Related]  

  • 49. Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
    McCloy RM; Baldus WP; Summerskill WH; Maher FT
    Ann Intern Med; 1966 Jun; 64(6):1271-6. PubMed ID: 4286738
    [No Abstract]   [Full Text] [Related]  

  • 50. The pathophysiology of cirrhotic edema: a reexamination of the "underfilling" and "overflow" hypotheses.
    Norris SH; Buell JC; Kurtzman NA
    Semin Nephrol; 1987 Jun; 7(2):99-105. PubMed ID: 3629030
    [No Abstract]   [Full Text] [Related]  

  • 51. Proceedings: Effects of angiotensin on kidney function.
    Leyssac PP
    J Endocrinol; 1976 Mar; 68(3):5P. PubMed ID: 1255109
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal response to lower body positive pressure produced by military anti-shock trousers.
    Krishna GG; Danovitch GM
    Am J Nephrol; 1984; 4(1):13-8. PubMed ID: 6731495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Radionephrographic study in hepatic cirrhosis under basal conditions and during angiotensin infusion].
    Bernardi P; Puddu P; Azzolini U; Pecoraro F; Poggiopollini G; Gola G; Cané G; Adani C
    G Clin Med; 1977; 58(11-12):428-35. PubMed ID: 608555
    [No Abstract]   [Full Text] [Related]  

  • 54. [Blood volume and urinary sodium, potassium and uric acid in cirrhosis. Evidence of the hypersensitivity of the nephron to aldosterone].
    Decaux G; Hanson B; Cauchie P; Bosson D; Unger J
    Acta Gastroenterol Belg; 1986; 49(1):13-9. PubMed ID: 3766056
    [No Abstract]   [Full Text] [Related]  

  • 55. [Suppression by spirolactones of the natriuretic effect of angiotensin peculiar to certain cirrhotics].
    Stahl J; Jahn H; Réville P; Kurtz T; Kuntzmann F
    C R Acad Hebd Seances Acad Sci D; 1965 Dec; 261(23):5247-9. PubMed ID: 4285131
    [No Abstract]   [Full Text] [Related]  

  • 56. Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain.
    Limas CJ; Guiha NH; Lekagul O; Cohn JN
    Circulation; 1974 Apr; 49(4):754-60. PubMed ID: 4361711
    [No Abstract]   [Full Text] [Related]  

  • 57. [Development of renal function after induction of anesthesia].
    Mercatello A; Mongin-Long D; Chabrol B; Baude C; Wehrlin P; Hadj Aissa A; Pozet N; Dubernard JM; Moskovtchenko JF
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R43. PubMed ID: 2604236
    [No Abstract]   [Full Text] [Related]  

  • 58. Effective blood volume: an effective concept or a modern myth.
    Michell AR
    Perspect Biol Med; 1996; 39(4):471-90. PubMed ID: 8753754
    [No Abstract]   [Full Text] [Related]  

  • 59. Cirrhosis and renal function.
    Kahn A
    J Ark Med Soc; 1971 Jul; 68(2):83-4. PubMed ID: 4254845
    [No Abstract]   [Full Text] [Related]  

  • 60. [Nephrotic syndrome].
    Takahashi S; Kawamura H; Takeuchi M; Hatano M
    Nihon Rinsho; 1982; 40(9):2017-20. PubMed ID: 6759714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.